Intravitreal Ketorolac for Chronic Uveitis: A Investigational Safety Study

Phase 1 Completed 10 enrolled Vanderbilt University

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Intraocular delivery of ketorolac will be an effective means to treat inflammation and macular edema and prevent structural complications and vision loss in patients with uveitis who are unable to tolerate corticosteroids due to their side effects.

Timeline

Start: 2009-12
Primary completion: 2010-12
Completion: 2010-12

Publications

Results Kim SJ, Doherty TJ, Cherney EF. Intravitreal ketorolac for chronic uveitis and macular edema: a pilot study. Arch Ophthalmol. 2012 Apr;130(4):456-60. doi: 10.1001/archopthalmol.2011.2627.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ketorolac	Other / unclassified	4 mg	Intravitreal

Indications

No indication recorded.